GSK-239512
Modify Date: 2025-09-03 12:28:04
GSK-239512 structure
|
Common Name | GSK-239512 | ||
|---|---|---|---|---|
| CAS Number | 720691-69-0 | Molecular Weight | 377.479 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 607.6±55.0 °C at 760 mmHg | |
| Molecular Formula | C23H27N3O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 321.3±31.5 °C | |
Use of GSK-239512GSK239512 is a potent and brain penetrated H3 receptor antagonist. GSK239512 can be used for the research of mild-to-moderate Alzheimer's disease (AD)[1]. |
| Name | GSK-239512 |
|---|---|
| Synonym | More Synonyms |
| Description | GSK239512 is a potent and brain penetrated H3 receptor antagonist. GSK239512 can be used for the research of mild-to-moderate Alzheimer's disease (AD)[1]. |
|---|---|
| Related Catalog | |
| Target |
H3 receptor |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 607.6±55.0 °C at 760 mmHg |
| Molecular Formula | C23H27N3O2 |
| Molecular Weight | 377.479 |
| Flash Point | 321.3±31.5 °C |
| Exact Mass | 377.210327 |
| LogP | 2.94 |
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
| Index of Refraction | 1.627 |
| Storage condition | 2-8°C |
| 2-Pyrrolidinone, 1-[6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl]- |
| MFCD27922168 |
| GSK-239512 |
| 1-{6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone |